5th Drug Discovery Innovation Programme 24-25 May 2018, Boston, US


5th Drug Discovery Innovation programme 24-25 May 2018 Embassy Suites by Hilton Boston at Logan Airport Boston, US. This is a two days event, our professionals will be talking on new compounds, target validation and novel drug design methods and technologies.

Programme Highlights:

  • Target engagementDualsystems-Biotech-AG-Dr-Paul-Helbling-CEO-2016
  • Advances in medicinal chemistry
  • Pre-clinical pharmacokinetics
  • Modern approaches for drug design
  • Role of AI in drug discovery
  • Open innovation
  • Computational approaches
  • Molecular dynamics
  • Biologics as potential therapeutics

Dr. Paul Helbling from Dualsystems Biotech AG is talking about “LRC-TriCEPS target identification on living cells”,  so you can learn more about the new LRC-TriCEPS (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells.

If you would like to meet Paul you can reach him via email paul.helbling@dualsystems.com or mobile +41 76 422 55 05